Travel fund to Swiss Nordic Bio 2019
| Reference number | |
| Coordinator | RED GLEAD DISCOVERY AB |
| Funding from Vinnova | SEK 6 815 |
| Project duration | February 2019 - February 2019 |
| Status | Completed |
Important results from the project
Participation completed including seminars, panel sessions and presence at multiple pitch presentations by various biotech companies in the early stage (potential Red Glead clients) as well as 6 scheduled1-to-1 meetings. The most important goal of effectively reaching more Life Science actors in Switzerland and the Nordics within the drug discovery space was fulfilled.
Expected long term effects
The most important effects were deepened relations with Novartis plus a couple of identified opportunities for research collaborations with other biotech companies. On a longer perspective, 1-2 new clients may be the result partly due to this meeting. Relevant intelligence updates on the Swiss and Nordic Life Science scene were effectively obtained.
Approach and implementation
CEO Johan Evenäs represented Red Glead Discovery during the meeting. Several new business contacts were made as well as maintained and deepened relations with previous contacts. Follow-up activities planned with Business Sweden.